← Back to Clinical Trials
Recruiting NCT07488741

NCT07488741 Comparison of the Effects of Different Chest Techniques on University Students With Smoking Addiction

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07488741
Status Recruiting
Phase
Sponsor University of Yalova
Condition Smoking
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2026-03-09
Primary Completion 2026-10-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 24 Years
Study Type INTERVENTIONAL
Interventions
Chest PNF Techniques GroupChest Mobility Exercises Group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2026-03-09 with a primary completion date of 2026-10-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Smoking is a significant risk factor for heart, lung, and respiratory system diseases, and is particularly prevalent among young people and university students. In Turkey, tobacco use is high in the 15-24 age group, and smoking rates among university students are reported to be between 20% and 43%. Besides causing COPD and other respiratory diseases, smoking negatively impacts performance by increasing fatigue, dyspnea, and pain during exercise. It impairs lung function, reducing respiratory volumes such as FVC and FEV1. PNF and chest mobility exercises targeting the chest area can improve respiratory parameters by increasing respiratory muscle function and thoracic mobility. Recent studies show that chest PNF techniques have positive effects on lung function, chest expansion, and some physiological parameters, especially in smokers.

Eligibility Criteria

Inclusion Criteria: * Age of 18-24 years * Fagerström Nicotine Dependence Questionnaire score ≥4 * Smoking for at least 2 years * Daily smoking ≥5 cigarettes and at least 90 pack-years. Stable condition (no acute respiratory infection in the last 4 weeks). * FEV1 ≥80% * Voluntary participation in the study * No orthopedic or neurological problems that would prevent participation in exercise Exclusion Criteria: * Cardiac event or lung surgery in the last 6 months * Respiratory problems such as COPD, asthma * Orthopedic and neurological problems * Termination of volunteering

Contact & Investigator

Central Contact

Gözde ARICA, MSc

✉ gozde.arica@yalova.edu.tr

📞 +905318893236

Principal Investigator

Büşra KAYABINAR, PhD

PRINCIPAL INVESTIGATOR

University of Yalova

Frequently Asked Questions

Who can join the NCT07488741 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 24 Years, studying Smoking. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07488741 currently recruiting?

Yes, NCT07488741 is actively recruiting participants. Contact the research team at gozde.arica@yalova.edu.tr for enrollment information.

Where is the NCT07488741 trial being conducted?

This trial is being conducted at Yalova, Turkey (Türkiye).

Who is sponsoring the NCT07488741 clinical trial?

NCT07488741 is sponsored by University of Yalova. The principal investigator is Büşra KAYABINAR, PhD at University of Yalova. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology